The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review.
HIV
HPV
HPV-related cancers
Sub-Saharan Africa
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
22 04 2020
22 04 2020
Historique:
received:
27
08
2018
accepted:
08
04
2020
entrez:
24
4
2020
pubmed:
24
4
2020
medline:
25
6
2021
Statut:
epublish
Résumé
People living with HIV (PLHIV) are at a high risk of developing HPV-related cancers. HPV-related malignancies occur frequently and/or are high among PLHIV, with cervical cancer as a designated AIDS-defining condition. We aimed to explore the evidence on the interplay of HIV and HPV-related cancers in sub-Saharan Africa (SSA). The scoping review was guided by Arksey and O'Malley's framework. We searched for literature from the following databases: PubMed; World Health Organization (WHO) Library; Science Direct; Google Scholar and EBSCOhost (Academic search complete, Health Source: Nursing/Academic Edition, CINAHL). Studies reporting on evidence HIV and HPV-related cancers interplay in SSA were eligible for inclusion in this review. The Mixed Methods Appraisal Tool (MMAT) tool was used to assess the risk of bias of the included studies. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was used for reporting the search results. Thematic analysis used to reveal the emerging themes from the included studies. A total of 74 potentially eligible articles were screened. Of these, nine (7 reviews, 1 transversal case controls, and 1 quantitative study) were eligible for data extraction. The studies reported about a total of 16,351 participants in different settings. The nine included studies showed evidence of cervical cancer among HIV-infected women and distribution of HPV infection and cervical abnormalities among HIV-positive individuals. In the four studies generalizing about HIV and anal cancer, only one reported about HPV. Two studies generally reported about HIV and head and neck cancers and one reported about interaction of HIV with vaginal cancer, vulvar cancer, and penile cancer, respectively. HIV positivity is associated with increased prevalence of HPV infection on different anatomic sites, which will result in increased burden of HPV-related cancers among PLHIV. Furthermore, primary studies with robust study designs aimed at investigating the risk developing HPV-related cancers among PLHIV are recommended. Systematic review registration: PROSPERO CRD42017062403.
Sections du résumé
BACKGROUND
People living with HIV (PLHIV) are at a high risk of developing HPV-related cancers. HPV-related malignancies occur frequently and/or are high among PLHIV, with cervical cancer as a designated AIDS-defining condition. We aimed to explore the evidence on the interplay of HIV and HPV-related cancers in sub-Saharan Africa (SSA).
METHODS
The scoping review was guided by Arksey and O'Malley's framework. We searched for literature from the following databases: PubMed; World Health Organization (WHO) Library; Science Direct; Google Scholar and EBSCOhost (Academic search complete, Health Source: Nursing/Academic Edition, CINAHL). Studies reporting on evidence HIV and HPV-related cancers interplay in SSA were eligible for inclusion in this review. The Mixed Methods Appraisal Tool (MMAT) tool was used to assess the risk of bias of the included studies. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was used for reporting the search results. Thematic analysis used to reveal the emerging themes from the included studies.
RESULTS
A total of 74 potentially eligible articles were screened. Of these, nine (7 reviews, 1 transversal case controls, and 1 quantitative study) were eligible for data extraction. The studies reported about a total of 16,351 participants in different settings. The nine included studies showed evidence of cervical cancer among HIV-infected women and distribution of HPV infection and cervical abnormalities among HIV-positive individuals. In the four studies generalizing about HIV and anal cancer, only one reported about HPV. Two studies generally reported about HIV and head and neck cancers and one reported about interaction of HIV with vaginal cancer, vulvar cancer, and penile cancer, respectively.
CONCLUSION
HIV positivity is associated with increased prevalence of HPV infection on different anatomic sites, which will result in increased burden of HPV-related cancers among PLHIV. Furthermore, primary studies with robust study designs aimed at investigating the risk developing HPV-related cancers among PLHIV are recommended. Systematic review registration: PROSPERO CRD42017062403.
Identifiants
pubmed: 32321580
doi: 10.1186/s13643-020-01354-1
pii: 10.1186/s13643-020-01354-1
pmc: PMC7178989
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
88Références
Curr Oncol Rep. 2014 Sep;16(9):402
pubmed: 25118645
Am J Obstet Gynecol. 2015 Sep;213(3):278-309
pubmed: 25797230
PLoS One. 2013 Nov 11;8(11):e78718
pubmed: 24244346
Curr Opin Oncol. 2007 Sep;19(5):446-51
pubmed: 17762569
Br J Cancer. 2007 May 7;96(9):1480-3
pubmed: 17437020
Int J Cancer. 2016 Nov 1;139(9):2001-11
pubmed: 27343048
Pediatr Dermatol. 2010 Mar-Apr;27(2):166-9
pubmed: 20537068
Vaccine. 2013 Oct 25;31(45):5152-67
pubmed: 24029117
Cancer Res. 2014 Dec 1;74(23):6833-44
pubmed: 25273091
Oral Oncol. 2012 Dec;48(12):1191-201
pubmed: 22841677
Gynecol Oncol. 2011 Nov;123(2):179-81
pubmed: 22008409
Prev Chronic Dis. 2014 May 15;11:E80
pubmed: 24831284
J Natl Cancer Inst. 2005 Apr 20;97(8):577-86
pubmed: 15840880
Oral Oncol. 2014 Jan;50(1):27-31
pubmed: 24169586
Int J Cancer. 2012 Nov 1;131(9):1969-82
pubmed: 22623137
Ann Intern Med. 2015 Oct 6;163(7):507-18
pubmed: 26436616
Cancer. 2010 Jun 1;116(11):2635-44
pubmed: 20336792
N Engl J Med. 2007 May 10;356(19):1928-43
pubmed: 17494926
Lancet. 2007 Jul 7;370(9581):59-67
pubmed: 17617273
Curr Opin HIV AIDS. 2017 Jan;12(1):26-30
pubmed: 27828801
J Clin Oncol. 2015 Jul 20;33(21):2376-83
pubmed: 26077242
J Natl Cancer Inst Monogr. 2003;(31):57-65
pubmed: 12807947
J Natl Cancer Inst. 2009 Aug 19;101(16):1120-30
pubmed: 19648510
Int J STD AIDS. 1999 Dec;10(12):803-7
pubmed: 10639061
Acta Cytol. 2009 Jan-Feb;53(1):10-7
pubmed: 19248549
J Clin Pathol. 2002 Apr;55(4):244-65
pubmed: 11919208
Am J Epidemiol. 2000 Jun 15;151(12):1148-57
pubmed: 10905527
Trop Med Int Health. 2009 Oct;14(10):1287-302
pubmed: 19772550
J Med Virol. 2005 Jan;75(1):105-13
pubmed: 15543579
Sex Transm Dis. 2002 Aug;29(8):427-35
pubmed: 12172526
J Natl Cancer Inst Monogr. 2003;(31):41-6
pubmed: 12807944
N Engl J Med. 2007 May 10;356(19):1944-56
pubmed: 17494927
J Otolaryngol Head Neck Surg. 2011 Feb;40 Suppl 1:S65-9
pubmed: 21453664
Vaccine. 2013 Dec 31;31 Suppl 7:H1-31
pubmed: 24332295
Curr HIV/AIDS Rep. 2015 Mar;12(1):6-15
pubmed: 25644977
Laryngoscope. 2016 Apr;126(4):894-900
pubmed: 26845348
Obstet Gynecol. 1997 Jan;89(1):71-5
pubmed: 8990441
J Clin Oncol. 2008 Feb 1;26(4):612-9
pubmed: 18235120
Vaccine. 2011 Jul 18;29(32):5245-9
pubmed: 21616117
Semin Oncol. 2015 Apr;42(2):272-83
pubmed: 25843731
Curr Opin Infect Dis. 2009 Apr;22(2):109-14
pubmed: 19276878
J Adolesc Health. 2010 Apr;46(4 Suppl):S20-6
pubmed: 20307840
J Natl Cancer Inst. 2007 Jun 20;99(12):962-72
pubmed: 17565153
Obstet Gynecol. 2008 Jun;111(6):1380-7
pubmed: 18515522
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):122-33
pubmed: 22045700
Curr Oncol Rep. 2010 Mar;12(2):115-20
pubmed: 20425596
J Natl Cancer Inst. 1999 Feb 3;91(3):226-36
pubmed: 10037100
Curr Opin HIV AIDS. 2011 Jul;6(4):297-302
pubmed: 21519247
J Natl Cancer Inst Monogr. 1998;(23):15-20
pubmed: 9709296
Oncol Res Treat. 2017;40(6):334-340
pubmed: 28521311
Womens Health (Lond). 2008 Jul;4(4):357-68
pubmed: 19072501
Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25
pubmed: 16949997
N Engl J Med. 2003 Feb 6;348(6):518-27
pubmed: 12571259
JAMA. 2000 Feb 23;283(8):1031-7
pubmed: 10697063
Cancer Prev Res (Phila). 2012 Jan;5(1):18-23
pubmed: 22219162
Medicine (Baltimore). 2017 Jan;96(4):e5948
pubmed: 28121939
Sex Transm Dis. 2005 May;32(5):314-20
pubmed: 15849533
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Int J Biol Markers. 2016 Apr-Jun;31(2):0
pubmed: 27040135
Adv Dent Res. 2011 Apr;23(1):84-9
pubmed: 21441487
Am J Pathol. 2014 Dec;184(12):3376-83
pubmed: 25455689
Cancer Lett. 2014 Sep 1;351(2):198-205
pubmed: 24971935
Int J Infect Dis. 2007 Nov;11 Suppl 2:S3-9
pubmed: 18162244
Curr Opin HIV AIDS. 2009 Jan;4(1):52-6
pubmed: 19339939
Cancer. 2017 Oct 15;123(20):4013-4021
pubmed: 28608917
CMAJ Open. 2014 Jul 22;2(3):E127-32
pubmed: 25114894
Virol Sin. 2015 Apr;30(2):92-100
pubmed: 25924993
Clin Dermatol. 1997 May-Jun;15(3):439-47
pubmed: 9255449
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Gynecol Oncol. 1998 Mar;68(3):233-9
pubmed: 9570972
Cancer Epidemiol. 2016 Dec;45:91-97
pubmed: 27780076
Curr Opin Oncol. 2006 Sep;18(5):463-8
pubmed: 16894294
Curr HIV/AIDS Rep. 2012 Sep;9(3):278-86
pubmed: 22744002
Porto Biomed J. 2016 Mar-Apr;1(1):29-31
pubmed: 32258543
J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1563-5
pubmed: 15577408
N Engl J Med. 1997 Nov 6;337(19):1343-9
pubmed: 9358128
Nursing. 2010 Oct;40(10):22-8; quiz 28-9
pubmed: 20827230
Br J Cancer. 2012 Jul 10;107(2):243-54
pubmed: 22699825
Infect Agent Cancer. 2016 Aug 15;11:43
pubmed: 27528886
Oral Oncol. 2014 Dec;50(12):1169-76
pubmed: 25301563
Oral Oncol. 2017 Apr;67:138-145
pubmed: 28351568
Int J Cancer. 2006 Feb 15;118(4):985-90
pubmed: 16106415
Infect Dis Obstet Gynecol. 2011;2011:675858
pubmed: 21785556
J Natl Cancer Inst. 2000 Sep 20;92(18):1500-10
pubmed: 10995805
J Natl Cancer Inst. 2013 Sep 18;105(18):1335-6
pubmed: 23990671
J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30
pubmed: 11078759
Med Oncol. 2015 Apr;32(4):109
pubmed: 25750043
Otolaryngol Clin North Am. 2012 Aug;45(4):807-22
pubmed: 22793854
AIDS. 2007 Sep 12;21(14):1957-63
pubmed: 17721103
AIDS. 2000 Aug 18;14(12):1775-84
pubmed: 10985315
J Am Osteopath Assoc. 2008 Apr;108(4 Suppl 2):S2-7
pubmed: 18463361
Infect Dis Clin North Am. 2013 Dec;27(4):765-78
pubmed: 24275269
Syst Rev. 2017 Nov 17;6(1):229
pubmed: 29149907
Neth J Med. 2013 Oct;71(8):401-11
pubmed: 24127500
J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):390-9
pubmed: 22820809
Vaccine. 2012 Nov 20;30 Suppl 4:D1-83, vi
pubmed: 23510764
PLoS One. 2016 Apr 06;11(4):e0152828
pubmed: 27050815
Am J Nurs. 2017 Jan;117(1):34-39
pubmed: 28030405
Am J Obstet Gynecol. 1998 May;178(5):982-6
pubmed: 9609571
JAMA. 2001 Apr 4;285(13):1736-45
pubmed: 11277828
Sex Transm Infect. 2012 Nov;88(7):517-21
pubmed: 22645393
Vaccine. 2013 Dec 29;31 Suppl 5:F32-46
pubmed: 24331746
J Natl Cancer Inst. 1995 Jun 7;87(11):796-802
pubmed: 7791229
J Natl Cancer Inst. 2005 Mar 16;97(6):425-32
pubmed: 15770006
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2442-6
pubmed: 19690181
Prev Med. 2016 Sep;90:52-8
pubmed: 27370167
Curr Opin Oncol. 2008 Sep;20(5):541-6
pubmed: 19106657
Sex Transm Dis. 2013 Jul;40(7):592-8
pubmed: 23965778
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
pubmed: 23199955
N Engl J Med. 2007 May 10;356(19):1915-27
pubmed: 17494925